XML 42 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Accounting Changes and Error Corrections
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2021
Accounting Changes and Error Corrections [Abstract]    
Restatement of Previously Issued Condensed Financial Statements
Consolidated Statements of Operations
Three Months Ended September 30,
2021
As Originally ReportedRestatement ImpactsAs Restated
Revenues, net$442,117 $— $442,117 
Operating expenses:
Cost of revenues(1)
(141,111)374 (140,737)
Selling, general and administrative costs(1)
(141,219)(3,626)(144,845)
Depreciation(2,657)— (2,657)
Amortization(128,026)— (128,026)
Restructuring and impairment(1)
(15,621)8,555 (7,066)
Other operating expense, net(4,411)— (4,411)
Total operating expenses(433,045)5,303 (427,742)
Income (loss) from operations9,072 5,303 14,375 
Mark to market adjustment on financial instruments83,013 — 83,013 
Income (loss) before interest expense and income tax92,085 5,303 97,388 
Interest expense and amortization of debt discount, net(65,194)— (65,194)
Income (loss) before income tax26,891 5,303 32,194 
Provision for income taxes(3,579)(191)(3,770)
Net income (loss)23,312 5,112 28,424 
Dividends on preferred shares(22,431)— (22,431)
Net income (loss) attributable to ordinary shares$881 $5,112 $5,993 
Per share:
Basic$— $0.01 $0.01 
Diluted$— $0.01 $0.01 
Weighted average shares used to compute earnings per share:
Basic640,834,827 634,508,967 634,508,967 
Diluted645,933,513 639,607,653 639,607,653 
(1) Includes correction and recording of share-based compensation charges over the vesting period within the Selling, general and administrative and Cost of revenues line items as well as accelerated charges for involuntarily terminated participants within the Restructuring and impairment line item as described in Note 2 - Basis of Presentation. 		Restatement of Prior Period Financial Statements
Subsequent to the original issuance of its Consolidated Financial Statements, the Company identified certain errors in its historical annual Consolidated Financial Statements, related to the accounting treatment of warrants. As such, the restated audited Consolidated Financial Statements for the years ended December 31, 2020 and 2019, and the unaudited interim Condensed Consolidated Financial Statements for the quarterly periods within these years commencing with the second quarter of 2019, are defined as the “Restated Periods."

See Note 2 - Basis of Presentation, Note 26 - Quarterly Financial Data, and Note 28 - Restatement of Previously Issued Financial Statements, to the Consolidated Financial Statements in the Amendment No. 2 ("10-K Amendment No. 2") to the Form 10-K for the year ended December 31, 2020.

The Company previously restated the accompanying interim Condensed Consolidated Financial Statements as of and for the quarter ended September 30, 2020 to correct for the impact of the misstatements. The applicable notes to the accompanying financial statements have also been corrected to reflect the impact of the restatement. Below, we have presented a reconciliation from the "As Originally Reported" to the "As Restated" amounts for each of our interim Condensed Consolidated Financial Statements as of and for the three and nine months ended September 30, 2020. The amounts "As Originally Reported" are from the "As Originally Reported" amounts as disclosed in Note 26 - Quarterly Financial Data in the 10-K Amendment No. 2.
The Company is filing this Amendment No. 1 ("Amendment No.1") of the Form 10-Q/A to amend our Quarterly Report on Form 10-Q for the period ended September 30, 2021, filed with the SEC on October 28, 2021 (the “Original Form 10-Q"), to restate our Condensed Consolidated Financial Statements and related footnote disclosures as of and for the three and nine months ended September 30, 2021. See Note 27 - Restatement of Previously Issued Financial Statements, for additional information related to the restatement, including descriptions of the misstatements and the impacts to previously reported financial information.
Interim Condensed Consolidated Statements of Operations (Unaudited)
Three months ended September 30, 2020
As Originally ReportedReclassification (a)Restatement ImpactsRestatement ReferenceAs Reclassified and Restated
Revenues, net$284,360 $— $— $284,360 
Operating expenses:
Cost of revenues(91,805)(1,749)— (93,554)
Selling, general and administrative costs(91,319)(40,207)— (131,526)
Share-based compensation expense(6,796)6,796 — — 
Depreciation(2,918)— — (2,918)
Amortization(65,696)— — (65,696)
Transaction expenses(34,938)34,938 — — 
Transition, integration and other related expenses(222)222 — — 
Restructuring and impairment(3,192)— — (3,192)
Other operating income, net(138)— — (138)
Total operating expenses(297,024)— — (297,024)
Loss from operations(12,664)— — (12,664)
Mark to market on financial instruments— — (144,753)(b)(144,753)
Loss before interest expense and income tax(12,664)— (144,753)(157,417)
Interest expense and amortization of debt discount, net(20,244)— — (20,244)
Loss before income tax(32,908)— (144,753)(b)(177,661)
Provision for income taxes(4,325)— — (4,325)
Net loss$(37,233)$— $(144,753)(b)$(181,986)
Per share:
Basic and diluted$(0.10)$(0.37)$(0.47)
Weighted average shares used to compute earnings per share:
Basic and diluted387,845,438 387,845,438 387,845,438 
(a) Reclassifications - The reclassifications are needed to conform to the current financial statement line items on the Condensed Consolidated Statements of Operations.
(b) Mark to market adjustment on financial instruments - The correction of these misstatements resulted in an adjustment of $144,753 that was recorded through the Statement of Operations, increasing the Net loss for the three months ended September 30, 2020.
Interim Condensed Consolidated Statements of Operations (Unaudited)
Nine Months Ended September 30, 2020
As Originally ReportedReclassification (a)Restatement ImpactsRestatement ReferenceAs Reclassified and Restated
Revenues, net$798,452 $— $— $798,452 
Operating expenses:
Cost of revenues(265,063)(3,551)— (268,614)
Selling, general and administrative costs(266,749)(101,498)— (368,247)
Share-based compensation expense(31,121)31,121 — — 
Depreciation(8,151)— — (8,151)
Amortization(168,049)— — (168,049)
Transaction expenses(70,154)70,154 — — 
Transition, integration and other related expenses(3,774)3,774 — — 
Restructuring and impairment(26,792)— — (26,792)
Other operating income, net14,675 — — 14,675 
Total operating expenses(825,178)— — (825,178)
Loss from operations(26,726)— — (26,726)
Mark to market on financial instruments— — (224,175)(b)(224,175)
Loss before interest expense and income tax(26,726)— (224,175)(250,901)
Interest expense and amortization of debt discount, net(72,306)— — (72,306)
Loss before income tax(99,032)— (224,175)(b)(323,207)
Provision for income taxes(13,693)— — (13,693)
Net loss$(112,725)$— $(224,175)(b)$(336,900)
Per share:
Basic and diluted$(0.31)$(0.61)$(0.91)
Weighted average shares used to compute earnings per share:
Basic and diluted369,019,802 369,019,802 369,019,802 

(a) Reclassifications - The reclassifications are needed to conform to the current financial statement line items on the Condensed Consolidated Statements of Operations.
(b) Mark to market adjustment on financial instruments - The correction of these misstatements resulted in an adjustment of $224,175 that was recorded through the Statement of Operations, increasing the Net loss for the nine months ended September 30, 2020.
Consolidated Statements of Comprehensive Income (Loss) (Unaudited)
Three months ended September 30, 2020
As Originally ReportedRestatement ImpactsAs Restated
Net loss$(37,233)(144,753)$(181,986)
Other comprehensive income (loss), net of tax:
Interest rate swaps1,092 — 1,092 
Defined benefit pension plans, net of tax(15)— (15)
Foreign currency translation adjustment9,359 — 9,359 
Total other comprehensive loss, net of tax10,436 — 10,436 
Comprehensive loss$(26,797)$(144,753)$(171,550)
Nine Months Ended September 30, 2020
As Originally ReportedRestatement ImpactsAs Restated
Net loss$(112,725)$(224,175)$(336,900)
Other comprehensive income (loss), net of tax:
Interest rate swaps(2,052)— (2,052)
Defined benefit pension plans, net of tax(57)— (57)
Foreign currency translation adjustment1,795 — 1,795 
Total other comprehensive loss, net of tax(314)— (314)
Comprehensive loss$(113,039)$(224,175)$(337,214)
Interim Condensed Consolidated Statement of Changes in Equity (Unaudited)
Share CapitalAccumulated
Other
Comprehensive
Income (Loss)		Accumulated
Deficit		Total
Shareholders’
 Equity
Restatement ReferenceSharesAmount
Balance at December 31, 2019306,874,115 $2,144,372 $(4,879)$(890,894)$1,248,599 
Adjustment to opening Accumulated deficit related to adoption of ASC Topic 326— — — (9,319)(9,319)
Exercise of public warrants (As Restated)28,880,098 277,526 — — 277,526 
Exercise of stock options3,715,455 1,182 — — 1,182 
Vesting of restricted stock units169,842 — — — — 
Shares returned to the Company for net share settlements(2,301,458)(10,302)— — (10,302)
Issuance of ordinary shares, net27,600,000 539,714 — — 539,714 
Share-based award activity— 16,384 — — 16,384 
Net loss (As Restated)(c)— — — (129,633)(129,633)
Other comprehensive income (loss) — — (8,470)— (8,470)
Balance at March 31, 2020 (As Restated)(c)364,938,052 2,968,876 (13,349)(1,029,846)1,925,681 
Exercise of stock options3,723,332 — — — — 
Vesting of restricted stock units2,528 — — — — 
Shares returned to the Company for net share settlements(2,311,293)(15,118)— — (15,118)
Issuance of ordinary shares, net20,982,500 304,030 — — 304,030 
Share-based award activity— 4,322 — — 4,322 
Net loss (As Restated)(c)— — — (25,281)(25,281)
Other comprehensive income (loss)— — (2,280)— (2,280)
Balance at June 30, 2020 (As Restated)(c)387,335,119 3,262,110 (15,629)(1,055,127)2,191,354 
Exercise of stock options4,068,307 125 — — 125 
Vesting of restricted stock units2,459 — — — — 
Shares returned to the Company for net share settlements(2,184,918)(3,136)— — (3,136)
Share-based award activity— 5,520 — — 5,520 
Net loss (As Restated)(c)— — — (181,986)(181,986)
Other comprehensive income (loss)— — 10,436 — 10,436 
Balance at September 30, 2020 (As Restated)(c)389,220,967 $3,264,619 $(5,193)$(1,237,113)$2,022,313 
(c) The correction of these misstatements include the mark to market adjustment on financial instruments. The correction of these misstatements resulted in an adjustment of $144,753 and $224,175 for the three and nine months ended September 30, 2020, respectively, that was recorded through the Statement of Operations, increasing the Net (loss).
Interim Condensed Consolidated Statement of Cash Flows (Unaudited)

Nine months ended September 30, 2020
As Originally ReportedRestatement ImpactsAs Restated
Cash Flows From Operating Activities
Net loss$(112,725)$(224,175)$(336,900)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization176,200 — 176,200 
Bad debt expense1,830 — 1,830 
Gain on sale of line of business(1,052)(1,052)
Restructuring and impairment4,880 — 4,880 
Gain on foreign currency forward contracts(2,903)— (2,903)
Deferred income tax benefit(7,420)— (7,420)
Share-based compensation26,344 — 26,344 
Mark to market adjustment on contingent and phantom shares (1)
30,839 — 30,839 
Mark to market adjustment on financial instruments (As Restated)— 224,175 224,175 
Deferred finance charges3,140 — 3,140 
Other operating activities(3,902)— (3,902)
Changes in operating assets and liabilities:
Accounts receivable129,398 — 129,398 
Prepaid expenses(13,335)— (13,335)
Other assets62,818 — 62,818 
Accounts payable(8,394)— (8,394)
Accrued expenses and other current liabilities(65,062)— (65,062)
Deferred revenues(93,926)— (93,926)
Operating lease right of use assets5,826 — 5,826 
Operating lease liabilities(6,611)— (6,611)
Other liabilities2,077 — 2,077 
Net cash provided by operating activities128,022 — 128,022 
Cash Flows From Investing Activities
Capital expenditures(78,597)— (78,597)
Acquisitions, net of cash acquired(885,323)— (885,323)
Acquisition of intangible assets(5,982)— (5,982)
Proceeds from sale of product line, net of restricted cash3,751 — 3,751 
Net cash used in investing activities(966,151)— (966,151)
Cash Flows From Financing Activities
Principal payments on term loan(9,450)— (9,450)
Repayments of revolving credit facility(65,000)— (65,000)
Payment of debt issuance costs(5,267)— (5,267)
Contingent purchase price payment(4,115)— (4,115)
Proceeds from issuance of debt360,000 — 360,000 
Proceeds from issuance of ordinary shares843,752 — 843,752 
Proceeds from warrant exercises277,526 — 277,526 
Proceeds from stock options exercised1,307 — 1,307 
Payments related to tax withholding for stock-based compensation(28,674)— (28,674)
Net cash provided by (used in) financing activities1,370,079 — 1,370,079 
Effects of exchange rates(6,447)— (6,447)
Net increase in cash and cash equivalents, and restricted cash525,503 — 525,503 
Beginning of period:
Cash and cash equivalents76,130 — 76,130 
Restricted cash9 — 9 
Total cash and cash equivalents, and restricted cash, beginning of period76,139 — 76,139 
Cash and cash equivalents, and restricted cash, end of period601,642 — 601,642 
End of period:
Cash and cash equivalents601,075 — 601,075 
Restricted cash567 — 567 
Total cash and cash equivalents, and restricted cash, end of period$601,642 $— $601,642 
Supplemental Cash Flow Information
Cash paid for interest$61,796 $— $61,796 
Cash paid for income tax$20,147 $— $20,147 
Capital expenditures included in accounts payable$922 $— $922 
Restatement of Previously Issued Financial Statements
As disclosed in the 10-K Amendment No. 2 filed with the SEC on February 3, 2022, the Company identified certain errors in its historical annual Consolidated Financial Statements related to the accounting treatment of certain awards made by CPA Global under the CPA Global Phantom Equity Plan that were incorrectly included as part of the acquisition accounting for the CPA Global Transaction. For the majority of these awards, the Company concluded that expenses should have been recognized as share-based compensation charges over the vesting period from October 1, 2020 to October 1, 2021 with only a portion of the liability recorded as part of acquisition accounting. The Company concluded that the financial statements previously issued as of and for the year ended December 31, 2020, and the quarterly period ended December 31, 2020 were misstated.

We also concluded that the impact was material to the Company’s financial statements prepared according to U.S. GAAP. As such, the restated unaudited Consolidated Financial Statements for the quarterly period ended September 30, 2021, are defined as the “Restated Periods."
This Note 27 to the Company’s Condensed Consolidated Financial Statements discloses the restatement impact on the originally reported financial statements for the quarterly period ended September 30, 2021 and the nature of the associated adjustments. The corrections included in the Consolidated Financial Statements contained herein are further described below.
The restatement included in these Condensed Consolidated Financial Statements was prepared following an independent review by the Audit Committee of the Company’s Board.
See Note 26 - Quarterly Financial Data and Note 28 - Restatement of Previously Issued Financial Statements, to the Consolidated Financial Statements in 10-K Amendment No. 2 for additional information related to the restatements.
Consolidated Balance Sheets
As of September 30,
2021
As Originally ReportedRestatement ImpactsAs Restated
Assets
Current assets:
Cash and cash equivalents$2,479,880 $— $2,479,880 
Restricted cash(1)
1,854,257 3,400 1,857,657 
Accounts receivable, net of allowance of $8,642 and $8,745 at September 30, 2021 and December 31, 2020, respectively
610,755 — 610,755 
Prepaid expenses58,056 — 58,056 
Other current assets(2)
186,298 (144,106)42,192 
Total current assets5,189,246 (140,706)5,048,540 
Property and equipment, net27,948 — 27,948 
Other intangible assets, net6,964,081 — 6,964,081 
Goodwill(3)
6,198,701 (199,379)5,999,322 
Other non-current assets(2)
41,808 (12,810)28,998 
Deferred income taxes30,110 (1,641)28,469 
Operating lease right-of-use assets45,880 — 45,880 
Total Assets$18,497,774 $(354,536)$18,143,238 
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable$94,494 $— $94,494 
Accrued expenses and other current liabilities(3)
592,721 (33,028)559,693 
Current portion of deferred revenues579,935 — 579,935 
Current portion of operating lease liability28,459 — 28,459 
Current portion of long-term debt1,865,627 — 1,865,627 
Total current liabilities3,161,236 (33,028)3,128,208 
Long-term debt3,443,578 — 3,443,578 
Warrant liabilities195,952 — 195,952 
Non-current portion of deferred revenues44,934 — 44,934 
Other non-current liabilities(3)
58,332 (8,372)49,960 
Deferred income taxes(4)
324,959 4,796 329,755 
Operating lease liabilities58,443 — 58,443 
Total liabilities7,287,434 (36,604)7,250,830 
Commitments and contingencies
Shareholders’ equity:
Preferred Shares, no par value; 14,375,000 shares authorized; 5.25% Mandatory Convertible Preferred Shares, Series A, 14,375,000 and 0 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively
1,392,671 — 1,392,671 
Ordinary Shares, no par value; unlimited shares authorized at September 30, 2021 and December 31, 2020; 639,750,620 and 606,329,598 shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively
10,810,130 — 10,810,130 
Treasury Shares, at cost; 6,325,860 and 6,325,860 at September 30, 2021 and December 31, 2020, respectively(2)
— (196,038)(196,038)
Accumulated other comprehensive income324,904 (6,896)318,008 
Accumulated deficit(1,317,365)(114,998)(1,432,363)
Total shareholders’ equity11,210,340 (317,932)10,892,408 
Total Liabilities and Shareholders’ Equity$18,497,774 $(354,536)$18,143,238 

(1) Represents restricted cash acquired to fund fixed cash awards and certain taxes related to the phantom equity compensation plan as part of CPA Global acquisition accounting.
(2) Includes correction of 6,325,860 shares that were transferred from Leonard Green & Partners, L. P. to an Employee Benefit Trust established for the CPA Equity Plan that should have been excluded from the purchase price consideration in the amount of $196,038.
(3) In connection with Amendment No. 2, the Company concluded that expenses should have been recognized as share-based compensation charges over the vesting period from October 1, 2020 to October 1, 2021, with only a portion of the liability recorded as part of acquisition accounting as described in Note 2 - Basis of Presentation.
(4) Separate from the CPA Global Equity Plan restatement in Amendment No 2, the Company has corrected the acquisition accounting understatement of deferred tax liabilities of $3,328 with an offset to goodwill relating to the CPA Global acquisition opening balance sheet on October 1, 2020, as well as an understatement of deferred tax liabilities of $1,936 with an offset to goodwill relating to the DRG acquisition opening balance sheet on February 28, 2020.
Nine Months Ended September 30,
2021
As Originally ReportedRestatement ImpactsAs Restated
Revenues, net$1,316,192 $— $1,316,192 
Operating expenses:
Cost of revenues(1)
(416,459)(21,852)(438,311)
Selling, general and administrative costs(1)
(402,378)(56,469)(458,847)
Depreciation(9,243)— (9,243)
Amortization(383,270)— (383,270)
Restructuring and impairment(1)
(121,988)(3,697)(125,685)
Other operating expense, net(19,741)— (19,741)
Total operating expenses(1,353,079)(82,018)(1,435,097)
Income (loss) from operations(36,887)(82,018)(118,905)
Mark to market adjustment on financial instruments113,207 — 113,207 
Income (loss) before interest expense and income tax76,320 (82,018)(5,698)
Interest expense and amortization of debt discount, net(141,156)— (141,156)
Income (loss) before income tax(64,836)(82,018)(146,854)
Provision for income taxes(18,016)5,776 (12,240)
Net income (loss)(82,852)(76,242)(159,094)
Dividends on preferred shares(22,431)— (22,431)
Net income (loss) attributable to ordinary shares$(105,283)$(76,242)$(181,525)
Per share:
Basic$(0.17)$(0.12)$(0.29)
Diluted$(0.17)$(0.12)$(0.29)
Weighted average shares used to compute earnings per share:
Basic622,460,931 616,135,071 616,135,071 
Diluted622,460,931 616,135,071 616,135,071 
(1) Includes correction and recording of share-based compensation charges over the vesting period within the Selling, general and administrative and Cost of revenues line items as well as accelerated charges for involuntarily terminated participants within the Restructuring and impairment line item as described in Note 2 - Basis of Presentation.
Consolidated Statements of Comprehensive Income (Loss)
Three Months Ended September 30,
2021
As Originally ReportedRestatement ImpactsAs Restated
Net income (loss)$23,312 $5,112 $28,424 
Other comprehensive income (loss), net of tax:
Interest rate swaps333 — 333 
Defined benefit pension plans(4)— (4)
Foreign currency translation adjustment(246,979)5,559 (241,420)
Total other comprehensive income (loss), net of tax(246,650)5,559 (241,091)
Comprehensive loss$(223,338)$10,671 $(212,667)

Consolidated Statements of Comprehensive Income (Loss)
Nine Months Ended September 30,
2021
As Originally ReportedRestatement ImpactsAs Restated
Net loss$(82,852)$(76,242)$(159,094)
Other comprehensive income (loss), net of tax:
Interest rate swaps1,884 — 1,884 
Defined benefit pension plans(12)— (12)
Foreign currency translation adjustment(180,489)4,243 (176,246)
Total other comprehensive loss, net of tax(178,617)4,243 (174,374)
Comprehensive loss$(261,469)$(71,999)$(333,468)
Consolidated Statements of Changes in Equity
As Restated
Ordinary SharesPreferred SharesTreasury SharesAccumulated
Other
Comprehensive
Income (Loss)		Accumulated
Deficit		Total
Shareholders’
 Equity
SharesAmountSharesAmountSharesAmount
Balance at December 31, 2020606,329,598 $9,989,284 —$— 6,325,860 $(196,038)$492,382 $(1,250,838)$9,034,790 
Exercise of Private Placement Warrants212,174 3,592 —— — — — — 3,592 
Exercise of stock options835,917 5,074 —— — — — — 5,074 
Vesting of restricted stock units15,958 — —— — — — — — 
Shares returned to the Company for net share settlements(434,059)(4,489)—— — — — — (4,489)
Issuance of ordinary shares, net4,395,638 105,509 —— — — — — 105,509 
Share-based award activity— 10,479 —— — — — — 10,479 
Net loss— — —— — — — (55,951)(55,951)
Other comprehensive income— — —— — — 19,593 — 19,593 
Balance at March 31, 2021611,355,226 $10,109,449 — $— 6,325,860 $(196,038)$511,975 $(1,306,789)$9,118,597 
Exercise of stock options1,581,518 9,761 —— — — — — 9,761 
Vesting of restricted stock units446,324 — —— — — — — — 
Shares returned to the Company for net share settlements(809,644)(17,245)—— — — — — (17,245)
Issuance of ordinary shares, net206,052,933 5,780,933 —— — — — — 5,780,933 
Repurchase of ordinary shares— — —— (177,206,779)(5,052,165)— — (5,052,165)
Retirement of treasury shares(177,206,779)(5,052,165)—— 177,206,779 5,052,165 — — — 
Share-based award activity— 12,816 —— — — — — 12,816 
Issuance of preferred shares, net— — 14,375,0001,393,222 — — — — 1,393,222 
Net loss— — —— — — — (131,567)(131,567)
Other comprehensive income— — —— — — 47,124 — 47,124 
Balance at June 30, 2021641,419,578$10,843,54914,375,000$1,393,2226,325,860$(196,038)$559,099$(1,438,356)$11,161,476
Exercise of stock options328,5312,415——————2,415
Vesting of restricted stock units114,962————————
Shares returned to the Company for net share settlements(177,481)279——————279
Issuance of ordinary shares, net—(688)——————(688)
Repurchases of ordinary shares————(2,599,700)(65,215)——(65,215)
Retirement of treasury shares(2,599,700)(65,215)——2,599,70065,215———
Share-based award activity—13,649——————13,649
Issuance of preferred shares, net———(551)————(551)
Dividends to preferred stockholders664,73016,141—————(22,431)(6,290)
Net income—— —— —— — 28,424 28,424 
Other comprehensive loss—— —— —— (241,091)— (241,091)
Balance at September 30, 2021 (As Restated)639,750,620$10,810,13014,375,000$1,392,6716,325,860$(196,038)$318,008$(1,432,363)$10,892,408
Nine Months Ended September 30,
2021
As Originally ReportedRestatement ImpactsAs Restated
Cash Flows From Operating Activities
Net loss$(82,852)$(76,242)$(159,094)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization392,513 — 392,513 
Bad debt expense6,832 — 6,832 
Deferred income tax benefit(11,084)8 (11,076)
Share-based compensation36,944 (33,890)3,054 
Restructuring and impairment60,232 (9,253)50,979 
Loss (gain) on foreign currency forward contracts4,026 — 4,026 
Mark to market adjustment on contingent and phantom shares(34,503)9,418 (25,085)
Mark to market adjustment on financial instruments(113,207)— (113,207)
Deferred finance charges9,050 — 9,050 
Other operating activities3,565 — 3,565 
Changes in operating assets and liabilities:
Accounts receivable114,038 — 114,038 
Prepaid expenses(887)— (887)
Other assets60,749 — 60,749 
Accounts payable13,550 — 13,550 
Accrued expenses and other current liabilities(14,208)104,647 90,439 
Deferred revenues(116,312)— (116,312)
Operating lease right of use assets16,838 — 16,838 
Operating lease liabilities(37,362)— (37,362)
Other liabilities(2,407)5,312 2,905 
Net cash provided by operating activities305,515 — 305,515 
Cash Flows From Investing Activities
Capital expenditures(86,197)— (86,197)
Acquisitions, net of cash acquired(14,314)— (14,314)
Net cash used in investing activities(100,511)— (100,511)
Cash Flows From Financing Activities
Proceeds from issuance of debt2,000,000 — 2,000,000 
Redemption of Notes not exchanged(157,424)— (157,424)
Principal payments on term loan(21,450)— (21,450)
Repayments of revolving credit facility— — — 
Payment of debt issuance costs(7,471)— (7,471)
Contingent purchase price payment— — — 
Proceeds from issuance of preferred shares1,392,671 — 1,392,671 
Nine Months Ended September 30,
2021
As Originally ReportedRestatement ImpactsAs Restated
Proceeds from issuance of ordinary shares728,080 — 728,080 
Repurchases of ordinary shares(65,215)— (65,215)
Cash dividends on preferred shares(1)— (1)
Proceeds from warrant exercises— — — 
Proceeds from stock options exercised17,250 — 17,250 
Payments related to tax withholding for stock-based compensation(21,455)— (21,455)
Net cash provided by financing activities3,864,985 — 3,864,985 
Effects of exchange rates(4,860)— (4,860)
Net increase in cash and cash equivalents, and restricted cash4,065,129 — 4,065,129 
Beginning of period:
Cash and cash equivalents$257,730 $— $257,730 
Restricted cash11,278 3,400 14,678 
Total cash and cash equivalents, and restricted cash, beginning of period269,008 3,400 272,408 
Less: Cash included in assets held for sale, end of period— — — 
Cash and cash equivalents, and restricted cash, end of period4,334,137 3,400 4,337,537 
End of period:
Cash and cash equivalents2,479,880 — 2,479,880 
Restricted cash1,854,257 3,400 1,857,657 
Total cash and cash equivalents, and restricted cash, end of period$4,334,137 $3,400 $4,337,537 
Supplemental Cash Flow Information:
Cash paid for interest$97,401 $— $97,401 
Cash paid for income tax$22,387 $— $22,387 
Capital expenditures included in accounts payable$6,612 $— $6,612 
Non-Cash Financing Activities:
Shares issued to Capri Acquisition Topco Limited$5,052,165 $— $5,052,165 
Retirement of treasury shares(5,117,380)— (5,117,380)
Shares issued as contingent stock consideration associated with the DRG acquisition
61,619 — 61,619 
Shares issued as contingent stock consideration associated with the CPA Global acquisition
43,890 — 43,890 
Shares issued as dividends on our 5.25% Series A Mandatory Convertible Preferred Shares16,141 — 16,141 
Dividends accrued on our 5.25% Series A Mandatory Convertible Preferred Shares6,289 — 6,289 
Total Non-Cash Financing Activities$62,724 $— $62,724